Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | Guridi-Legarra, J. (Jorge) | - |
dc.creator | Gonzalez-Redondo, R. (R.) | - |
dc.creator | Obeso, J.A. (José A.) | - |
dc.date.accessioned | 2014-02-27T11:42:35Z | - |
dc.date.available | 2014-02-27T11:42:35Z | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | Guridi J, González-Redondo R, Obeso JA. Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease. Parkinsons Dis. 2012;2012:943159. | es_ES |
dc.identifier.issn | 2042-0080 | - |
dc.identifier.uri | https://hdl.handle.net/10171/35304 | - |
dc.description.abstract | Dyskinetic disorders are characterized by excess of motor activity that may interfere with normal movement control. In patients with Parkinson's disease, the chronic levodopa treatment induces dyskinetic movements known as levodopa-induced dyskinesias (LID). This paper analyzed the pathophysiology, clinical manifestations, pharmacological treatments, and surgical procedures to treat hyperkinetic disorders. Surgery is currently the only treatment available for Parkinson's disease that may improve both parkinsonian motor syndrome and LID. However, this paper shows the different mechanisms involved are not well understood. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Hindawi Publishing Corporation | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Clinical features | es_ES |
dc.subject | Dyskinetic disorders | es_ES |
dc.subject | Parkinson's disease | es_ES |
dc.title | Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.